Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Callahan

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|September 29, 2016
High clinical and morphologic response using <sup>90</sup>Y-DOTA-octreotate sequenced with <sup>177</sup>Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumoursGrace Kong, Jason Callahan, Michael S Hofman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 23, 2013
Validation of a 4D-PET maximum intensity projection for delineation of an internal target volumeJason Callahan, Tomas Kron, Michal Schneider-Kolsky, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse SurvivalSarah Everitt, David Ball, Rodney J Hicks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2013
18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experienceShankar Siva, Keelan Byrne, Matthew Seel, et al.
BMC Cancer|October 4, 2014
A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancerShankar Siva, Jason Callahan, Tomas Kron, et al.
EJNMMI Research|October 12, 2017
Automatic delineation of functional lung volumes with <sup>68</sup>Ga-ventilation/perfusion PET/CTPierre-Yves Le Roux, Shankar Siva, Jason Callahan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2024
Dose-Response Relationships Between Radiation Exposure, Bone Marrow Function as Measured by <sup>18</sup>F-Fluorothymidine Positron Emission Tomography, and Lymphocyte Counts During Chemoradiation for Non-Small Cell Lung CancerMichael P MacManus, Elizabeth Prins, Jing Xie, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy PlanningBelinda A Campbell, Jason Callahan, Mathias Bressel, et al.
Cancer|July 13, 2010
High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancerSarah Everitt, Alan Herschtal, Jason Callahan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 16, 2015
¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival dataShankar Siva, Siddhartha Deb, Richard J Young, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Nuclear Medicine and Molecular Imaging|September 29, 2016
High clinical and morphologic response using <sup>90</sup>Y-DOTA-octreotate sequenced with <sup>177</sup>Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumoursGrace Kong, Jason Callahan, Michael S Hofman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 23, 2013
Validation of a 4D-PET maximum intensity projection for delineation of an internal target volumeJason Callahan, Tomas Kron, Michal Schneider-Kolsky, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse SurvivalSarah Everitt, David Ball, Rodney J Hicks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2013
18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experienceShankar Siva, Keelan Byrne, Matthew Seel, et al.
BMC Cancer|October 4, 2014
A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancerShankar Siva, Jason Callahan, Tomas Kron, et al.
EJNMMI Research|October 12, 2017
Automatic delineation of functional lung volumes with <sup>68</sup>Ga-ventilation/perfusion PET/CTPierre-Yves Le Roux, Shankar Siva, Jason Callahan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2024
Dose-Response Relationships Between Radiation Exposure, Bone Marrow Function as Measured by <sup>18</sup>F-Fluorothymidine Positron Emission Tomography, and Lymphocyte Counts During Chemoradiation for Non-Small Cell Lung CancerMichael P MacManus, Elizabeth Prins, Jing Xie, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy PlanningBelinda A Campbell, Jason Callahan, Mathias Bressel, et al.
Cancer|July 13, 2010
High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancerSarah Everitt, Alan Herschtal, Jason Callahan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 16, 2015
¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival dataShankar Siva, Siddhartha Deb, Richard J Young, et al.
Pageof 9